Karen P. Robards, Director at BlackRock Health Sciences Trust II (BMEZ), bought 50 shares at $21.30 ($1K) on 2020-02-18, disclosed to the SEC on 2020-02-20.
Open-market purchase of $1k BMEZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| MSO | BUY | 2019-04-18 | $10K | — | Filing → |
| MSO | BUY | 2018-02-26 | $25K | — | Filing → |
| BKT | BUY | 2017-06-20 | $11K | — | Filing → |